Literature DB >> 11588181

Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice.

L Sörensen1, M Ekstrand, J P Silva, E Lindqvist, B Xu, P Rustin, L Olson, N G Larsson.   

Abstract

We generated mitochondrial late-onset neurodegeneration (MILON) mice with postnatal disruption of oxidative phosphorylation in forebrain neurons. They develop normally and display no overt behavioral disturbances or histological changes during the first 5 months of life. The MILON mice display reduced levels of mitochondrial DNA and mitochondrial RNA from 2 and 4 months of age, respectively, and severely respiratory chain-deficient neurons from 4 months of age. Surprisingly, these respiratory chain-deficient neurons are viable for at least 1 month without showing signs of neurodegeneration or major induction of defenses against oxidative stress. Prolonged neuronal respiratory chain deficiency is thus required for the induction of neurodegeneration. Before developing neurological symptoms, MILON mice show increased vulnerability to excitotoxic stress. We observed a markedly enhanced sensitivity to excitotoxic challenge, manifest as an abundance of terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) reactive cells after kainic acid injection, in 4-month-old MILON mice, showing that respiratory chain-deficient neurons are more vulnerable to stress. At approximately 5-5.5 months of age, MILON mice start to show signs of disease, followed by death shortly thereafter. The debut of overt disease in MILON mice coincides with onset of rapidly progressive neurodegeneration and massive cell death in hippocampus and neocortex. This profound neurodegenerative process is manifested as axonal degeneration, gliosis, and abundant TUNEL-positive nuclei. The MILON mouse model provides a novel and powerful tool for additional studies of the role for respiratory chain deficiency in neurodegeneration and aging.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588181      PMCID: PMC6763882     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities.

Authors:  N Darin; A Oldfors; A R Moslemi; E Holme; M Tulinius
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

2.  Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age.

Authors:  D A Cottrell; E L Blakely; M A Johnson; P G Ince; G M Borthwick; D M Turnbull
Journal:  Neurobiol Aging       Date:  2001 Mar-Apr       Impact factor: 4.673

3.  Subacute necrotizing encephalomyelopathy in an infant.

Authors:  D LEIGH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1951-08       Impact factor: 10.154

4.  Neuropathology in Kearns-Sayre syndrome.

Authors:  A Oldfors; I M Fyhr; E Holme; N G Larsson; M Tulinius
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle.

Authors:  E J Brierley; M A Johnson; R N Lightowlers; O F James; D M Turnbull
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

6.  Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA.

Authors:  V Geromel; N Kadhom; I Cebalos-Picot; O Ouari; A Polidori; A Munnich; A Rötig; P Rustin
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

Review 7.  Revolution in mitochondrial medicine.

Authors:  N G Larsson; R Luft
Journal:  FEBS Lett       Date:  1999-07-23       Impact factor: 4.124

8.  Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB.

Authors:  B Xu; K Zang; N L Ruff; Y A Zhang; S K McConnell; M P Stryker; L F Reichardt
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

Review 9.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

10.  Localization of cellular retinoid-binding proteins suggests specific roles for retinoids in the adult central nervous system.

Authors:  R H Zetterström; A Simon; M M Giacobini; U Eriksson; L Olson
Journal:  Neuroscience       Date:  1994-10       Impact factor: 3.590

View more
  71 in total

Review 1.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

2.  Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease.

Authors:  Maria Pilar Bayona-Bafaluy; Bas Blits; Brendan J Battersby; Eric A Shoubridge; Carlos T Moraes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-22       Impact factor: 11.205

3.  Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.

Authors:  Yuan-Hao Chen; Tsung-Hsun Hsieh; Tung-Tai Kuo; Jen-Hsin Kao; Kuo-Hsing Ma; Eagle Yi-Kung Huang; Yu-Ching Chou; Lars Olson; Barry J Hoffer
Journal:  J Neurochem       Date:  2019-05-09       Impact factor: 5.372

4.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

5.  Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function.

Authors:  Andreu Viader; Judith P Golden; Robert H Baloh; Robert E Schmidt; Daniel A Hunter; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

6.  Over-expression of the catalytic core of mitochondrial DNA (mtDNA) polymerase in the nervous system of Drosophila melanogaster reduces median life span by inducing mtDNA depletion.

Authors:  Francisco Martínez-Azorín; Manuel Calleja; Rosana Hernández-Sierra; Carol L Farr; Laurie S Kaguni; Rafael Garesse
Journal:  J Neurochem       Date:  2007-11-12       Impact factor: 5.372

7.  Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease.

Authors:  Hirokazu Fukui; Francisca Diaz; Sofia Garcia; Carlos T Moraes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

Review 8.  Running forward: new frontiers in endurance exercise biology.

Authors:  Glenn C Rowe; Adeel Safdar; Zolt Arany
Journal:  Circulation       Date:  2014-02-18       Impact factor: 29.690

9.  MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease.

Authors:  D Galter; K Pernold; T Yoshitake; E Lindqvist; B Hoffer; J Kehr; N-G Larsson; L Olson
Journal:  Genes Brain Behav       Date:  2009-10-07       Impact factor: 3.449

Review 10.  Mouse models of mitochondrial DNA defects and their relevance for human disease.

Authors:  Henna Tyynismaa; Anu Suomalainen
Journal:  EMBO Rep       Date:  2009-01-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.